Firefly Neuroscience highlighted two studies demonstrating the potential of its FDA-cleared Brain Network Analytics (BNA™) platform in drug development...

A Phase 3 CheckMate-8HW trial analysis revealed that Opdivo plus Yervoy significantly improved progression-free survival (PFS) compared to Opdivo...

Exelixis announced results from the STELLAR-001 trial, a Phase 1b/2 study evaluating zanzalintinib, alone or combined with atezolizumab, in...

In this conversation with Christine Guo, Chief Scientific Officer at ActiGraph, we explored the impact of Actigraph’s acquisition of...

Allurion Technologies plans to launch a clinical study combining its weight-loss program with GLP-1 agonists to address muscle loss,...

A Massachusetts General Hospital (MGH) study assessed the real-world impact of binx health’s point-of-care (POC) testing for chlamydia and...

Neuvivo announced promising results from a new analysis of its investigational immunotherapy NP001 for Amyotrophic Lateral Sclerosis (ALS). The...

Medidata, a Dassault Systèmes company, and Tigermed, a global clinical research provider, extended their 13-year partnership. This renewed collaboration...

Astria Therapeutics has launched a Phase 1a clinical trial for STAR-0310, a monoclonal antibody designed to treat atopic dermatitis...

Pluri Inc. secured a $6.5 million private investment from Alejandro Weinstein, who will join the company’s board. Simultaneously, Pluri...